Showing 48 companies
Founded in 2016, and 2017 graduate of Y Combinator, Advano is a New Orleans-based company delivering a scalable solution for lithium-ion batteries with higher energy density. By conquering the challenges of silicon, Advano integrates or completely replaces graphite in today’s lithium-ion batteries with its advanced silicon anode material - improving the longevity of lithium-ion batteries for blue chip battery manufacturers and Tier one consumer electronics and automotive companies.
ALICE enhances your construction planning and scheduling abilities to help keep crews flowing on any size project – so you can build faster and cheaper. Working directly with your 3D BIM and using a simple rule-based system, ALICE explores millions of different schedule sequences and gives teams the power to answer “What If?” scenarios and completely reschedule in just minutes. ALICE is quickly disrupting the $7 trillion construction industry by changing the way construction projects are planned, scheduled, and managed – saving our clients millions of dollars on the most exciting construction projects on the planet.
Anagram is making vision care more affordable and accessible for providers and consumers. Thousands of eye care practices use Anagram to operate independently, process out-of-network benefits, and deliver better pricing on eyewear for their patients.
Arable is a developer of an integrated system for agriculture that helps digitize and optimize decisions from seed breeding to food production. The platform measures everything that matters to the crop, from the weather to the soil, to the plant itself by the use of a unique set of spectral and thermal sensors. This enables Arable to observe a crop’s development through the season and determine the onset of stress due to a lack of water or nutrients. Its integrated hardware, agronomic modeling, and software suite is enabling farmers, agronomists, researchers, processors, and food companies to understand the crop system at the plant, field, and region level, which helps to reduce risk, improve productivity, and optimize for sustainability.
Astranis Space Technologies
Astranis is a developer of a new satellite technology that aims to transmit data down to specific terrestrial locations with each satellite it launches. The company's mission is to help get online the 4 billion people who are without internet access. It was founded in 2015 and is headquartered in San Francisco, California.
At Atom Computing, we’re our customers’ biggest fans on the journey of discovery. That’s why we’re obsessed with creating the world’s most scalable and reliable quantum computers—giving them the power to develop breakthroughs that change the world.
Bigfinite's goal is to be the global partner in providing simple solutions to the analysis and control complex needs of industrial processes in Biotech and Pharma, covering all the supply chain, from R+D to patient dispensing. By offering a SAAS application for industrial use, under the philosophy of “Internet of Things”, that can be quickly implemented, without having to adapt or change the currently existing systems and with a customer ROI under six months. With efficiency, collaboration, interdisciplinary, joy, respect, transparency & commitment.
CATALOG is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation.
Character Biosciences (formerly Clover Therapeutics) is a precision medicine platform that is unlocking the patterns of age-related diseases in people of diverse backgrounds. Our mission is to use human genetics to understand what drives diseases so we can discover targeted therapies to more effectively treat patients - many of whom lack any treatment options today. Character partners with patients, providers, payers, and scientists to create deeply-phenotyped patient cohorts to enable clinical genomic research. Our approach integrates genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify the molecular drivers of disease progression and develop innovative targeted medicines.